Blog

The Label-free cell analysis technology, using HoloMonitor cell-based assays, is an easy way to capture cell events and more information from individual cells.

A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.

Interim Report 1 (2019-05-01 – 2019-07-31) from Phase Holographic Imaging.

Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.  

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542-7811, kallas härmed till årsstämma tisdagen den 15 oktober 2019 kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 9 oktober 2019, och …

The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.

PHI Board member Jan Richardsson recently divested 5 328 shares in the company. “The reason for the sale is that I needed to balance an option loss linked to a previous employment”, comments Richardsson.

In yet another publication scientists report on how HoloMonitor was used to study cell motility and migration for deeper understanding of cell biological processes.

Previously communicated publication date for Interim Report 1 2019/20 was incorrect. The correct publication date is September 23, 2019 and nothing else.